Carter Robert Ross bought TOI
November 17, 2025 · Form 4 insider transaction
Carter Robert Ross bought 195 shares of Starling Oncology Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
195
Price
$0.00
Total value
N/A
InsiderCarter Robert Ross
Role—
CompanyStarling Oncology Inc (TOI)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after235,369
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSU awards that were fully vested upon grant, net of withholding tax obligations.